Panakis Niki, McNair Helen A, Christian Judith A, Mendes Ruheena, Symonds-Tayler J Richard N, Knowles Clifford, Evans Philip M, Bedford James, Brada Michael
The Academic Unit of Radiotherapy and Oncology, The Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK.
Radiother Oncol. 2008 Apr;87(1):65-73. doi: 10.1016/j.radonc.2007.12.012. Epub 2008 Feb 11.
The effectiveness of ABC has been traditionally measured as the reduction in internal margin (IM) within the planning target volume (PTV). Not to overestimate the benefit of ABC, the effect of patient movement during treatment also needs to be taken into account. We determined the IM and set-up error with ABC and the effect on physical lung parameters compared to standard margins used with free breathing. We also assessed interfraction oesophageal movement to determine a planning organ at risk volume (PRV).
Two sequential studies were performed using ABC in NSCLC patients suitable for radical radiotherapy (RT). Twelve out of 14 patients in Study 1 had tumours visible fluoroscopically and had intrafraction tumour movement assessed with and without ABC. Sixteen patients were recruited to Study 2 and had interfraction tumour movement measured using ABC in a moderate deep inspiration breath-hold, of these 7 patients also had interfraction oesophageal movement recorded. Interfraction movement was assessed by CT scan prior to and in the middle and final week of RT. Displacement of the tumour centre of mass and oesophageal borders relative to the first scan provided a measure of movement. Set-up error was measured in 9 patients treated with an in-house lung board adapted for the ABC device. Combining movement and set-up errors determined PTV and PRV margins with ABC. The effect of ABC on mean lung dose (MLD), lung V20 and V13 was calculated.
ABC in a moderate deep inspiration breath-hold was tolerated in 25 out of 30 patients (83%) in Study 1 and 2. The random contribution of periodic tumour motion was reduced by 90% in the y direction with ABC compared to free-breathing. The magnitude of motion reduction was less in the x and z direction. Combining the systematic and random set-up error in quadrature with the systematic and random intrafraction and interfraction tumour variations with ABC results in a PTV margin of 8.3mm in the x direction, 12.0mm in the y direction and 9.8mm in the z direction. There was a relative mean reduction in MLD, lung V20 and V13 of 25%, 21% and 18% with the ABC PTV compared to a free-breathing PTV. Oesophageal movement combined with set-up error resulted in an isotropic PRV of 4.7 mm.
The reduction in PTV size with ABC resulted in an 18-25% relative reduction in physical lung parameters. PTV margin reduction has the potential to spare normal lung and allow dose-escalation if coupled with image-guided RT. The oesophageal PRV needs to be considered when irradiating central disease and is of increasing importance with altered RT fractionation and concomitant chemoradiation schedules. Further reductions in PTV and PRV may be possible if patient set-up error was minimised, confirming that attention to patient immobilisation is as important as attempts to control tumour motion.
传统上,主动呼吸控制(ABC)的有效性通过计划靶体积(PTV)内内部边界(IM)的缩小来衡量。为了不过高估计ABC的益处,还需要考虑治疗期间患者运动的影响。我们确定了使用ABC时的IM和摆位误差,以及与自由呼吸时使用的标准边界相比对肺物理参数的影响。我们还评估了分次间食管运动,以确定计划危及器官体积(PRV)。
对适合根治性放疗(RT)的非小细胞肺癌(NSCLC)患者进行了两项连续研究,使用ABC。研究1的14名患者中有12名肿瘤在荧光镜下可见,并在有和没有ABC的情况下评估了分次内肿瘤运动。16名患者被纳入研究2,并在中度深吸气屏气时使用ABC测量分次间肿瘤运动,其中7名患者还记录了分次间食管运动。在放疗前、放疗中期和放疗最后一周通过CT扫描评估分次间运动。肿瘤质心和食管边界相对于第一次扫描的位移提供了运动的测量值。在9名使用适合ABC设备的内部肺板治疗的患者中测量了摆位误差。结合运动和摆位误差确定了使用ABC时的PTV和PRV边界。计算了ABC对平均肺剂量(MLD)、肺V20和V13的影响。
研究1和2中,30名患者中有25名(83%)耐受中度深吸气屏气时的ABC。与自由呼吸相比,使用ABC时,周期性肿瘤运动的随机贡献在y方向减少了90%。在x和z方向运动减少的幅度较小。将系统和随机摆位误差与使用ABC时的系统和随机分次内及分次间肿瘤变化进行正交组合,得出PTV边界在x方向为8.3mm,y方向为12.0mm,z方向为9.8mm。与自由呼吸PTV相比,ABC PTV的MLD、肺V20和V13相对平均降低了25%、21%和18%。食管运动与摆位误差相结合,得出各向同性PRV为至4.7mm。
使用ABC导致PTV大小减小,使肺物理参数相对降低18 - 25%。如果与图像引导放疗相结合,PTV边界的减小有可能保护正常肺组织并允许剂量增加。在照射中央型病变时需要考虑食管PRV,并且随着放疗分次方案改变和同步放化疗方案的应用,其重要性日益增加。如果将患者摆位误差降至最低,PTV和PRV可能会进一步减小,这证实了关注患者固定与控制肿瘤运动同样重要。